ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 289 filers reported holding ICU MED INC in Q4 2021. The put-call ratio across all filers is 6.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,802 | -33.2% | 200 | 0.0% | 0.01% | -39.1% |
| Q2 2023 | $35,638 | +8.0% | 200 | 0.0% | 0.02% | +9.5% |
| Q1 2023 | $32,992 | +4.7% | 200 | 0.0% | 0.02% | +10.5% |
| Q4 2022 | $31,496 | +5.0% | 200 | 0.0% | 0.02% | -5.0% |
| Q3 2022 | $30,000 | -9.1% | 200 | 0.0% | 0.02% | -9.1% |
| Q2 2022 | $33,000 | -26.7% | 200 | 0.0% | 0.02% | -18.5% |
| Q1 2022 | $45,000 | -4.3% | 200 | 0.0% | 0.03% | -6.9% |
| Q4 2021 | $47,000 | 0.0% | 200 | 0.0% | 0.03% | -6.5% |
| Q3 2021 | $47,000 | +14.6% | 200 | 0.0% | 0.03% | +14.8% |
| Q2 2021 | $41,000 | 0.0% | 200 | 0.0% | 0.03% | -3.6% |
| Q1 2021 | $41,000 | -4.7% | 200 | 0.0% | 0.03% | -12.5% |
| Q4 2020 | $43,000 | +16.2% | 200 | 0.0% | 0.03% | +3.2% |
| Q3 2020 | $37,000 | 0.0% | 200 | 0.0% | 0.03% | -3.1% |
| Q2 2020 | $37,000 | -7.5% | 200 | 0.0% | 0.03% | -13.5% |
| Q1 2020 | $40,000 | +8.1% | 200 | 0.0% | 0.04% | +37.0% |
| Q4 2019 | $37,000 | +15.6% | 200 | 0.0% | 0.03% | +8.0% |
| Q3 2019 | $32,000 | -36.0% | 200 | 0.0% | 0.02% | -37.5% |
| Q2 2019 | $50,000 | +4.2% | 200 | 0.0% | 0.04% | +11.1% |
| Q1 2019 | $48,000 | +4.3% | 200 | 0.0% | 0.04% | -2.7% |
| Q4 2018 | $46,000 | -19.3% | 200 | 0.0% | 0.04% | 0.0% |
| Q3 2018 | $57,000 | -3.4% | 200 | 0.0% | 0.04% | -9.8% |
| Q2 2018 | $59,000 | +18.0% | 200 | 0.0% | 0.04% | +13.9% |
| Q1 2018 | $50,000 | +16.3% | 200 | 0.0% | 0.04% | +28.6% |
| Q4 2017 | $43,000 | +16.2% | 200 | 0.0% | 0.03% | +16.7% |
| Q3 2017 | $37,000 | +5.7% | 200 | 0.0% | 0.02% | +9.1% |
| Q2 2017 | $35,000 | +12.9% | 200 | 0.0% | 0.02% | +10.0% |
| Q1 2017 | $31,000 | +6.9% | 200 | 0.0% | 0.02% | +17.6% |
| Q4 2016 | $29,000 | +16.0% | 200 | 0.0% | 0.02% | +13.3% |
| Q3 2016 | $25,000 | +8.7% | 200 | 0.0% | 0.02% | +15.4% |
| Q2 2016 | $23,000 | +9.5% | 200 | 0.0% | 0.01% | +18.2% |
| Q1 2016 | $21,000 | -8.7% | 200 | 0.0% | 0.01% | -8.3% |
| Q4 2015 | $23,000 | +4.5% | 200 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $22,000 | +15.8% | 200 | 0.0% | 0.01% | +20.0% |
| Q2 2015 | $19,000 | 0.0% | 200 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $19,000 | +18.8% | 200 | 0.0% | 0.01% | +25.0% |
| Q4 2014 | $16,000 | – | 200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |